A booster was 95.6% effective against symptomatic Covid in the study, which followed 10,000 people aged 16 and older, the companies said in a statement Thursday. The fast-spreading delta variant was the predominate strain during the trial.from International-News-Economic Times https://ift.tt/3joJ7i3
via IFTTT
0 comments:
Post a Comment